Clinical Trials Insurance

Pharmaceutical companies invest a lot into research to find solutions or cures to large scale diseases or degenerative conditions. Presently, nearly two thirds of R&D costs go into drug development, of which clinical research accounts for 70 per cent of time and resources spent. Before a new drug is being released in the market, it needs to be tested for its safety and effectiveness on human subjects who volunteer to participate. The human subject can either be healthy volunteers or patients suffering from a disease for which the medicine is being tested. The test is intended to provide adequate information on drug use – on its safety, efficacy and possible adverse effects. This process is known as clinical trial or bioequivalence test, based on the kind of trial conducted.